Literature DB >> 21786289

Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population.

Hyun-Kyung Park1, Kyoung-Ryul Lee, Young-Jin Kim, Han-Ik Cho, Jung Eun Kim, Ki Woong Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee.   

Abstract

Research on the epidemiology of monoclonal gammopathy of undetermined significance (MGUS) is limited in Korea. The aim of this study was to determine the prevalence and characteristics of MGUS in an elderly urban Korean population. A random sample of 1118 Korean elders was selected from residents aged 65 years or older living in Seongnam, Korea 1 year from August 2005. We obtained plasma samples remaining after scheduled tests for the Korean Longitudinal Study on Health and Aging. The mean age of the study population was 72 years (range, 65-97 years). To screen for MGUS, immunofixation and free light-chain (FLC) assays were performed. Age-adjusted and gender-adjusted MGUS prevalence rates in 680 responders were estimated as 3.3% [95% confidence interval (CI) = 2.0-4.6%], and the estimated age-adjusted prevalence of MGUS was 4.3% in men (95% CI = 1.9-6.6%) and 2.6% in women (95% CI = 1.0-4.2%). Abnormal FLC ratios were detected in 10% of MGUS cases. Multivariate analysis of 945 participants revealed that significant risk factors for MGUS included advanced age, male sex, hyperproteinemia, increased erythrocyte sedimentation rate, and abnormal FLC ratio. MGUS is less prevalent among elderly Koreans (3.3%) than other races. This is the first study to estimate the prevalence of MGUS in the Korean elderly population. Our findings should be confirmed with additional studies analyzing follow-up samples from 2010.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786289     DOI: 10.1002/ajh.22095

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  MGUS prevalence in an ethnically Chinese population in Hong Kong.

Authors:  S Peter Wu; Alex Minter; Rene Costello; Adriana Zingone; Cheuk-Kwong Lee; Wing-Yan Au; Ola Landgren
Journal:  Blood       Date:  2013-03-21       Impact factor: 22.113

2.  The analytical performance evaluation of Freelite™ Human Kappa Free and Human Lambda Free on the SPAPLUS™ immunoturbidimetric analyzer.

Authors:  Kyong-Ho Cha; Yang Bo Sim; Hyojin Chae; Hae-il Park; Myungshin Kim; Yonggoo Kim
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

3.  Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort.

Authors:  Yun-Gyoo Lee; Soo-Mee Bang; Jeong-Ok Lee; Jin Won Kim; Keun-Wook Lee; Jee Hyun Kim; Jung Han Song; Tae-Hee Kim; Ki Woong Kim; Jong-Seok Lee
Journal:  Cancer Res Treat       Date:  2014-08-29       Impact factor: 4.679

Review 4.  Recent advances in multiple myeloma: a Korean perspective.

Authors:  Junshik Hong; Jae Hoon Lee
Journal:  Korean J Intern Med       Date:  2016-09-01       Impact factor: 2.884

5.  A nationwide study of patients with monoclonal gammopathy of undetermined significance with a 10-year follow-up in South Korea.

Authors:  Ka-Won Kang; Ji Eun Song; Byung-Hyun Lee; Min Ji Jeon; Eun Sang Yu; Dae Sik Kim; Se Ryeon Lee; Hwa Jung Sung; Chul Won Choi; Yong Park; Byung Soo Kim
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

6.  Association between the delta estimated glomerular filtration rate and the prevalence of monoclonal gammopathy of undetermined significance in Korean males.

Authors:  Tae-Dong Jeong; Woochang Lee; Sail Chun; Won-Ki Min
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.